pre-IC3 Flashcards
How do anti-platelets work?
Block platelet aggregation & primary haemostasis
4 key steps in haemostasis & thrombosis
- Vasoconstriction
- Primary haemostasis (recruitment of platelets & clotting factors)
- Secondary haemostasis (thrombin activation & fibrin polymerisation)
- Clot stabilisation
How do anti-coagulants work?
Block activation of fibrin polymerisation & secondary haemostasis
When does extrinsic pathway occur
Tissue damage
When does intrinsic pathway occur
Surface contact (e.g. with glass, collagen, or subendothelium)
MOA for warfarin
Vit K antagonist; Inhibits vitamin K reductase enzyme that reactivates oxidised vitamin K
Should vit K be active or inactive to achieve anti-coagulation? Hence should it be reduced or oxidised form?
Inactive form (oxidised); because the active form drives activation of clotting factors
Warfarin is primarily metabolised in the liver by _______
CYP2C9
What causes variability in warfarin response?
Genetic polymorphisms in CYP2C9 and vit K reductase complex subunit 1 (VKORC1)
Adverse effects of warfarin
- Haemorrhage/ bleeding
- Hepatitis
- Cutaneous necrosis
Contraindication for warfarin
- Active bleeding
- Severe or malignant HTN
- Severe renal/ hepatic disease
- Pregnancy
Reversal agent for warfarin
Vit K
Reversal agent for dabigatran
Idacizumab
MOA for dabigatran
Antagonist of thrombin (factor IIa)
*Competitive & reversible
MOA for rivaroxaban
Antagonist of activated factor Xa; competitive & reversible
Reversal agent for rivaroxaban & how it works
Andexanet alfa; acts as recombinant factor Xa
Which drug reduce dabigatran level?
Rifampin
Which kind of drug reduce rivaroxaban level?
P-glycoptn & CYP3A4 inducers
Adverse effects: rivaroxaban
bleeding